Tratamento da doença de Parkinson (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Tratamento da doença de Parkinson" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
5th place
5th place
1st place
1st place
3,258th place
5,177th place
18th place
51st place
low place
low place
621st place
1,847th place
12th place
21st place
low place
low place
low place
low place
102nd place
459th place
low place
low place
774th place
641st place
1,702nd place
3,295th place
7,997th place
low place
296th place
512th place
11th place
968th place
993rd place
547th place
cambridge-news.co.uk
- Thomas, Josh (9 de dezembro de 2016). «Cambridge inventor helps Parkinson's disease suffer to write again». cambridge-news.co.uk. Cambridgeshire, England: Cambridge News. Consultado em 15 de dezembro de 2016
connexionfrance.com
- Jane, Hanks (4 de abril de 2017). «Potential good news for Parkinson's sufferers». The Connexion. Consultado em 9 de junho de 2018
digitaltrends.com
- Jones, Brad (8 de dezembro de 2016). «Wearable Device Helps Steady Hand of Designer Who Has Parkinson's Disease». digitaltrends.com
doi.org
dx.doi.org
- Bronstein JM, Tagliati M, Alterman RL et al. «Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues». Arch Neurol. 68: 165–65. PMC 4523130
. PMID 20937936. doi:10.1001/archneurol.2010.260 - Ceravolo R, Frosini D, Rossi C, Bonuccelli U. «Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management». Parkinsonism Relat. Disord. 15 Suppl 4: S111–15. PMID 20123548. doi:10.1016/S1353-8020(09)70847-8
- Morelli. «A2AReceptor Antagonism and Dyskinesia in Parkinson's Disease». Parkinson's Disease. 2012. 489853 páginas. ISSN 2090-8083. PMC 3382949. PMID 22754707. doi:10.1155/2012/489853
- Armentero. «Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease». Pharmacology & Therapeutics. 132: 280–299. ISSN 0163-7258. PMC 3205226. PMID 21810444. doi:10.1016/j.pharmthera.2011.07.004
- Samii A, Nutt JG, Ransom BR. «Parkinson's disease». Lancet. 363: 1783–93. PMID 15172778. doi:10.1016/S0140-6736(04)16305-8
- Warner. «The Role of Atomoxetine for Parkinson Disease-Related Executive Dysfunction: A Systematic Review». Journal of Clinical Psychopharmacology. 38: 627–631. ISSN 1533-712X. PMID 30346335. doi:10.1097/JCP.0000000000000963
- Hasnain M, Vieweg WV, Baron MS, Beatty-Brooks M, Fernandez A, Pandurangi AK. «Pharmacological management of psychosis in elderly patients with parkinsonism». Am. J. Med. 122: 614–22. PMID 19559160. doi:10.1016/j.amjmed.2009.01.025
- Chung, KA. «Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease». Neurology. 75: 1263–69. PMC 3013493. PMID 20810998. doi:10.1212/WNL.0b013e3181f6128c
- Barichella M, Cereda E, Pezzoli G (1 de dezembro de 2009). «Major nutritional issues in the management of Parkinson's disease». Mov. Disord. 24 (13): 1881–92. PMID 19691125. doi:10.1002/mds.22705. hdl:2434/67795
- Barichella M, Cereda E, Pezzoli G. «Major nutritional issues in the management of Parkinson's disease». Mov. Disord. 24: 1881–92. PMID 19691125. doi:10.1002/mds.22705
- Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. «The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis». Mov. Disord. 23: 631–40. PMID 18181210. doi:10.1002/mds.21922
- Goodwin V. A., Richards S. H., Taylor R. S., Taylor A. H., Campbell J. L. (2008). «The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis». Movement Disorders. 23: 631–40. PMID 18181210. doi:10.1002/mds.21922
- Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (2006). «The science and practice of LSVT/LOUD: neural plasticityprincipled approach to treating individuals with Parkinson's disease and other neurological disorders». Semin Speech Lang. 27: 283–299. PMID 17117354. doi:10.1055/s-2006-955118
- Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG. «The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders». Seminars in Speech and Language. 27: 283–99. PMID 17117354. doi:10.1055/s-2006-955118
- Dixon L, Duncan D, Johnson P et al. (2007). «Occupational therapy for patients with Parkinson's disease». Cochrane Database Syst Rev. PMC 6991932. PMID 17636709. doi:10.1002/14651858.CD002813.pub2
- Dorsey. «Teleneurology and mobile technologies: the future of neurological care». Nature Reviews Neurology. 14: 285–297. ISSN 1759-4758. PMID 29623949. doi:10.1038/nrneurol.2018.31
- Roeder. «Effects of Resistance Training on Measures of Muscular Strength in People with Parkinson's Disease: A Systematic Review and Meta-Analysis». PLOS One. 10. Bibcode:2015PLoSO..1032135R. PMC 4492705. PMID 26146840. doi:10.1371/journal.pone.0132135
- Scandalis TA, Bosak A, Berliner JC, Helman LL, Wells MR (2001). «Resistance Training and Gait Function in Patients with Parkinson's Disease». Am J Phys Med Rehabil. 80: 38–43. PMID 11138953. doi:10.1097/00002060-200101000-00011
- Barichella. «Major nutritional issues in the management of Parkinson's disease.». Movement Disorders. 24: 1881–92. PMID 19691125. doi:10.1002/mds.22705
- Haas CT, Turbanski S, Kessler K, Schmidtbleicher D (2006). «The effects of random whole-body-vibration on motor symptoms in Parkinson's disease». NeuroRehabilitation. 21: 29–36. PMID 16720935. doi:10.3233/NRE-2006-21105
- King LK, Almeida QJ, Ahonen H (2009). «Short-term effects of vibration therapy on motor impairments in Parkinson's disease». NeuroRehabilitation. 25: 297–306. PMID 20037223. doi:10.3233/NRE-2009-0528
- Arias P, Chouza M, Vivas J, Cudeiro J (2009). «Effect of whole body vibration in Parkinson's disease: a controlled study». Movement Disorders. 24: 891–898. PMID 19199362. doi:10.1002/mds.22468
- Ebersbach G, Edler D, Kaufhold O, Wissel J (2008). «Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease». Archives of Physical Medicine and Rehabilitation. 89: 399–403. PMID 18295614. doi:10.1016/j.apmr.2007.09.031
- Sitjà Rabert M, Rigau Comas D, Fort Vanmeerhaeghe A, Santoyo Medina C, Roqué I, Figuls M, Romero-Rodríguez D, Bonfill Cosp X (2012). «Whole-body vibration training for patients with neurodegenerative disease». Cochrane Database of Systematic Reviews. 15. PMID 22336858. doi:10.1002/14651858.cd009097.pub2
- Zečević I. «Clinical Practice Guidelines Based on Evidence for Cognitive-Behavioral Therapy in Parkinson's Disease Comorbidities: A Literature Review». Clin Psychol Psychother (Review). PMID 32196842. doi:10.1002/cpp.2448}
- Spaulding, Sandi J., Brittany Barber, Morgan Colby, Bronwyn Cormack, Tanya Mick, et Mary E. Jenkins (2013). «Cueing and Gait Improvement among People with Parkinson's Disease: A Meta-Analysis». Archives of Physical Medicine and Rehabilitation. 94: 562–70. PMID 23127307. doi:10.1016/j.apmr.2012.10.026
- Bryant, M. S., D. H. Rintala, E. C. Lai, et E. J. Protas (2009). «An Evaluation of Self-Administration of Auditory Cueing to Improve Gait in People with Parkinson's Disease». Clinical Rehabilitation. 23: 1078–85. PMC 2877128. PMID 19565381. doi:10.1080/17483100903038576
- Morris ME, Iansek R, Matyas TA, Summers JJ (1996). «Stride length regulation in Parkinson's disease.Normalization strategies and underlying mechanisms». Brain. 119: 551–68. PMID 8800948. doi:10.1093/brain/119.2.551
- «Clinical Practice Guidelines Based on Evidence for Cognitive‐Behavioral Therapy in Parkinson's Disease Comorbidities: A Literature Review». Clinical Psychology & Psychotherapy. PMID 32196842. doi:10.1002/cpp.2448
- et al. (2002). «Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial». Arch Phys Med Rehabil. 83: 1370–73. PMID 12370870. doi:10.1053/apmr.2002.34603
- Amano S, Nocera JR, Vallabhajosula S, Juncos JL, Gregor RJ, Waddell DE, Wolf SL, Hass CJ (2013). «The effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's Disease». Parkinsonism Relat Disord. 19: 955–60. PMC 3825828. PMID 23835431. doi:10.1016/j.parkreldis.2013.06.007
- Hackney ME, Earhart GM (2008). «Tai Chi improves balance and mobility in people with Parkinson disease». Gait & Posture. 28: 456–60. PMC 2552999. PMID 18378456. doi:10.1016/j.gaitpost.2008.02.005
- Cannito MP, Suiter DM, Beverly D, Chorna L, Wolf T, Pfeiffer RM (2012). «Sentence Intelligibility Before and After Voice Treatment in Speakers With Idiopathic Parkinson's Disease». Journal of Voice. 26: 214–19. PMID 22209057. doi:10.1016/j.jvoice.2011.08.014
- «Speech and swallowing in parkinson's disease». Top Geriatric Rehabilitation. 28: 115–26. 2008. PMC 2784698. PMID 19946386. doi:10.1097/01.TGR.0000318899.87690.44
- Pacchetti C, Mancini F, Aglieri R, Fundaro C, Martignoni E, Nappi G (2000). «Active Music Therapy in Parkinson's Disease: An Integrative Method for Motor and Emotional Rehabilitation». Psychosomatic Medicine. 62: 386–93. CiteSeerX 10.1.1.555.3509. PMID 10845352. doi:10.1097/00006842-200005000-00012
- Beck. «National randomized controlled trial of virtual house calls for Parkinson disease». Neurology. 89: 1152–1161. ISSN 0028-3878. PMC 5595275. PMID 28814455. doi:10.1212/WNL.0000000000004357
- Dorsey. «National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers». Telemedicine and E-Health. 22: 590–598. ISSN 1530-5627. PMC 4939367. PMID 26886406. doi:10.1089/tmj.2015.0191
- Beck. «National randomized controlled trial of virtual house calls for Parkinson disease». Neurology. 89: 1152–1161. ISSN 1526-632X. PMC 5595275. PMID 28814455. doi:10.1212/WNL.0000000000004357
- Mammen. «Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study». Telemedicine and E-Health. 24: 255–267. ISSN 1530-5627. PMID 28787250. doi:10.1089/tmj.2017.0119
- Koch G (2010). «rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets». Restor. Neurol. Neurosci. 28: 561–68. PMID 20714078. doi:10.3233/RNN-2010-0556
- Platz T, Rothwell JC (2010). «Brain stimulation and brain repair – rTMS: from animal experiment to clinical trials – what do we know?». Restor. Neurol. Neurosci. 28: 387–98. PMID 20714064. doi:10.3233/RNN-2010-0570
- Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. «Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology». Neurology. 66: 976–82. PMID 16606908. doi:10.1212/01.wnl.0000206363.57955.1b
- Lee MS, Lam P, Ernst E. «Effectiveness of tai chi for Parkinson's disease: a critical review». Parkinsonism Relat. Disord. 14: 589–94. PMID 18374620. doi:10.1016/j.parkreldis.2008.02.003
- Lee MS, Ernst E. «Qigong for movement disorders: A systematic review». Mov. Disord. 24: 301–03. PMID 18973253. doi:10.1002/mds.22275
- Lee MS, Shin BC, Kong JC, Ernst E. «Effectiveness of acupuncture for Parkinson's disease: a systematic review». Mov. Disord. 23: 1505–15. PMID 18618661. doi:10.1002/mds.21993
- Katzenschlager R, Evans A, Manson A et al. (2004). «Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study». J. Neurol. Neurosurg. Psychiatry. 75: 1672–77. PMC 1738871. PMID 15548480. doi:10.1136/jnnp.2003.028761
- Ladha SS, Walker R, Shill HA. «Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance». Mov. Disord. 20: 630–31. PMID 15719433. doi:10.1002/mds.20380
- Raguthu L, Varanese S, Flancbaum L, Tayler E, Di Rocco A. «Fava beans and Parkinson's disease: useful 'natural supplement' or useless risk?». Eur. J. Neurol. 16. PMID 19678834. doi:10.1111/j.1468-1331.2009.02766.x
- Lanska DJ (2010). Chapter 33: the history of movement disorders. Col: Handbook of Clinical Neurology. 95. [S.l.: s.n.] pp. 501–46. ISBN 9780444520098. PMID 19892136. doi:10.1016/S0072-9752(08)02133-7
- Guridi J, Lozano AM. «A brief history of pallidotomy». Neurosurgery. 41: 1169–80; discussion 1180–83. PMID 9361073. doi:10.1097/00006123-199711000-00029
- Fahn S (2008). «The history of dopamine and levodopa in the treatment of Parkinson's disease». Mov. Disord. 23 Suppl 3: S497–508. PMID 18781671. doi:10.1002/mds.22028
- Fahn S (2008). «The history of dopamine and levodopa in the treatment of Parkinson's disease». Mov. Disord. 23 Suppl 3: S497–508. PMID 18781671. doi:10.1002/mds.22028
- Hornykiewicz O (2002). «L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent». Amino Acids. 23: 65–70. PMID 12373520. doi:10.1007/s00726-001-0111-9
- Coffey RJ. «Deep brain stimulation devices: a brief technical history and review». Artif Organs. 33: 208–20. PMID 18684199. doi:10.1111/j.1525-1594.2008.00620.x
- Obeso JA, Rodriguez-Oroz MC, Goetz CG et al. «Missing pieces in the Parkinson's disease puzzle». Nat Med. 16: 653–61. PMID 20495568. doi:10.1038/nm.2165
- Langston JW, Ballard P, Tetrud JW, Irwin I. «Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis» (PDF). Science. 219: 979–980. Bibcode:1983Sci...219..979L. PMID 6823561. doi:10.1126/science.6823561
- Cicchetti F, Drouin-Ouellet J, Gross RE. «Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?». Trends Pharmacol. Sci. 30: 475–83. PMID 19729209. doi:10.1016/j.tips.2009.06.005
- Transgenic rodent models of Parkinson's disease. Col: Acta Neurochirurgica Supplementum. 101. [S.l.: s.n.] 2008. pp. 89–92. ISBN 978-3-211-78204-0. PMC 2613245. PMID 18642640. doi:10.1007/978-3-211-78205-7_15
- Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW. «Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.». Lancet Neurology. 9: 1164–72. PMID 20970382. doi:10.1016/S1474-4422(10)70254-4. CN-00772567
- LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A. «AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial». Lancet Neurology. 10: 309–19. PMID 21419704. doi:10.1016/S1474-4422(11)70039-4. CN-00786419
- Feng, LR, Maguire-Zeiss KA (2010). «Gene Therapy in Parkinson's Disease: Rationale and Current Status». CNS Drugs. 24: 177–92. PMC 2886503. PMID 20155994. doi:10.2165/11533740-000000000-00000
- Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. (1 de maio de 2010). «Missing pieces in the Parkinson's disease puzzle». Nat Med. 16 (6): 653–61. PMID 20495568. doi:10.1038/nm.2165
- Redmond DE. «Cellular replacement therapy for Parkinson's disease – where we are today?». The Neuroscientist. 8: 457–88. PMID 12374430. doi:10.1177/107385802237703
efox.nl
- «Parkinson Home Exercises App». Efox.nl. European Foundation for Health and Exercise. Consultado em 4 de dezembro de 2015
genengnews.com
- Dimond PF (16 de agosto de 2010), «No New Parkinson Disease Drug Expected Anytime Soon», GEN-Genetic Engineering & Biotechnology News, GEN news highlights, consultado em 25 de outubro de 2010
- Dimond PF (16 de agosto de 2010), «No New Parkinson Disease Drug Expected Anytime Soon», GEN-Genetic Engineering & Biotechnology News, GEN news highlights, consultado em 25 de outubro de 2010
handle.net
hdl.handle.net
- Barichella M, Cereda E, Pezzoli G (1 de dezembro de 2009). «Major nutritional issues in the management of Parkinson's disease». Mov. Disord. 24 (13): 1881–92. PMID 19691125. doi:10.1002/mds.22705. hdl:2434/67795
harvard.edu
ui.adsabs.harvard.edu
- Roeder. «Effects of Resistance Training on Measures of Muscular Strength in People with Parkinson's Disease: A Systematic Review and Meta-Analysis». PLOS One. 10. Bibcode:2015PLoSO..1032135R. PMC 4492705. PMID 26146840. doi:10.1371/journal.pone.0132135
- Langston JW, Ballard P, Tetrud JW, Irwin I. «Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis» (PDF). Science. 219: 979–980. Bibcode:1983Sci...219..979L. PMID 6823561. doi:10.1126/science.6823561
metro.co.uk
- Mann, Tanveer (8 de dezembro de 2016). «Woman with Parkinson's can write again using incredible invention». metro.co.uk. Consultado em 15 de dezembro de 2016
neurologychannel.com
- Parkinson's disease surgery Arquivado em 2010-03-30 no Wayback Machine neurology Channel. Retrieved on 2010-02-02
newscientist.com
nice.org.uk
- The National Collaborating Centre for Chronic Conditions, ed. (2006). «Symptomatic pharmacological therapy in Parkinson's disease». Parkinson's Disease. London: Royal College of Physicians. pp. 59–100. ISBN 978-1-86016-283-1 Guidance was reviewed in 2011 and no changes were made. According to NICE as of July 2014 a revised guidance was under development with anticipated publication in 2017.
- The National Collaborating Centre for Chronic Conditions, ed. (2006). «Symptomatic pharmacological therapy in Parkinson's disease». Parkinson's Disease. Royal College of Physicians. London: [s.n.] pp. 59–100. ISBN 978-1-86016-283-1 Guidance was reviewed in 2011 and no changes were made. According to NICE as of July 2014 a revised guidance was under development with anticipated publication in 2017.
nih.gov
ncbi.nlm.nih.gov
- Bronstein JM, Tagliati M, Alterman RL et al. «Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues». Arch Neurol. 68: 165–65. PMC 4523130. PMID 20937936. doi:10.1001/archneurol.2010.260
- Ceravolo R, Frosini D, Rossi C, Bonuccelli U. «Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management». Parkinsonism Relat. Disord. 15 Suppl 4: S111–15. PMID 20123548. doi:10.1016/S1353-8020(09)70847-8
- Morelli. «A2AReceptor Antagonism and Dyskinesia in Parkinson's Disease». Parkinson's Disease. 2012. 489853 páginas. ISSN 2090-8083. PMC 3382949. PMID 22754707. doi:10.1155/2012/489853
- Armentero. «Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease». Pharmacology & Therapeutics. 132: 280–299. ISSN 0163-7258. PMC 3205226. PMID 21810444. doi:10.1016/j.pharmthera.2011.07.004
- Goldenberg MM. «Medical management of Parkinson's disease». P & T. 33: 590–606. PMC 2730785. PMID 19750042
- Samii A, Nutt JG, Ransom BR. «Parkinson's disease». Lancet. 363: 1783–93. PMID 15172778. doi:10.1016/S0140-6736(04)16305-8
- Warner. «The Role of Atomoxetine for Parkinson Disease-Related Executive Dysfunction: A Systematic Review». Journal of Clinical Psychopharmacology. 38: 627–631. ISSN 1533-712X. PMID 30346335. doi:10.1097/JCP.0000000000000963
- Hasnain M, Vieweg WV, Baron MS, Beatty-Brooks M, Fernandez A, Pandurangi AK. «Pharmacological management of psychosis in elderly patients with parkinsonism». Am. J. Med. 122: 614–22. PMID 19559160. doi:10.1016/j.amjmed.2009.01.025
- Chung, KA. «Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease». Neurology. 75: 1263–69. PMC 3013493. PMID 20810998. doi:10.1212/WNL.0b013e3181f6128c
- Barichella M, Cereda E, Pezzoli G (1 de dezembro de 2009). «Major nutritional issues in the management of Parkinson's disease». Mov. Disord. 24 (13): 1881–92. PMID 19691125. doi:10.1002/mds.22705. hdl:2434/67795
- Barichella M, Cereda E, Pezzoli G. «Major nutritional issues in the management of Parkinson's disease». Mov. Disord. 24: 1881–92. PMID 19691125. doi:10.1002/mds.22705
- Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. «The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis». Mov. Disord. 23: 631–40. PMID 18181210. doi:10.1002/mds.21922
- Goodwin V. A., Richards S. H., Taylor R. S., Taylor A. H., Campbell J. L. (2008). «The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis». Movement Disorders. 23: 631–40. PMID 18181210. doi:10.1002/mds.21922
- Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (2006). «The science and practice of LSVT/LOUD: neural plasticityprincipled approach to treating individuals with Parkinson's disease and other neurological disorders». Semin Speech Lang. 27: 283–299. PMID 17117354. doi:10.1055/s-2006-955118
- Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG. «The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders». Seminars in Speech and Language. 27: 283–99. PMID 17117354. doi:10.1055/s-2006-955118
- Dixon L, Duncan D, Johnson P et al. (2007). «Occupational therapy for patients with Parkinson's disease». Cochrane Database Syst Rev. PMC 6991932. PMID 17636709. doi:10.1002/14651858.CD002813.pub2
- Dorsey. «Teleneurology and mobile technologies: the future of neurological care». Nature Reviews Neurology. 14: 285–297. ISSN 1759-4758. PMID 29623949. doi:10.1038/nrneurol.2018.31
- Roeder. «Effects of Resistance Training on Measures of Muscular Strength in People with Parkinson's Disease: A Systematic Review and Meta-Analysis». PLOS One. 10. Bibcode:2015PLoSO..1032135R. PMC 4492705. PMID 26146840. doi:10.1371/journal.pone.0132135
- Scandalis TA, Bosak A, Berliner JC, Helman LL, Wells MR (2001). «Resistance Training and Gait Function in Patients with Parkinson's Disease». Am J Phys Med Rehabil. 80: 38–43. PMID 11138953. doi:10.1097/00002060-200101000-00011
- Barichella. «Major nutritional issues in the management of Parkinson's disease.». Movement Disorders. 24: 1881–92. PMID 19691125. doi:10.1002/mds.22705
- Haas CT, Turbanski S, Kessler K, Schmidtbleicher D (2006). «The effects of random whole-body-vibration on motor symptoms in Parkinson's disease». NeuroRehabilitation. 21: 29–36. PMID 16720935. doi:10.3233/NRE-2006-21105
- King LK, Almeida QJ, Ahonen H (2009). «Short-term effects of vibration therapy on motor impairments in Parkinson's disease». NeuroRehabilitation. 25: 297–306. PMID 20037223. doi:10.3233/NRE-2009-0528
- Arias P, Chouza M, Vivas J, Cudeiro J (2009). «Effect of whole body vibration in Parkinson's disease: a controlled study». Movement Disorders. 24: 891–898. PMID 19199362. doi:10.1002/mds.22468
- Ebersbach G, Edler D, Kaufhold O, Wissel J (2008). «Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease». Archives of Physical Medicine and Rehabilitation. 89: 399–403. PMID 18295614. doi:10.1016/j.apmr.2007.09.031
- Sitjà Rabert M, Rigau Comas D, Fort Vanmeerhaeghe A, Santoyo Medina C, Roqué I, Figuls M, Romero-Rodríguez D, Bonfill Cosp X (2012). «Whole-body vibration training for patients with neurodegenerative disease». Cochrane Database of Systematic Reviews. 15. PMID 22336858. doi:10.1002/14651858.cd009097.pub2
- Zečević I. «Clinical Practice Guidelines Based on Evidence for Cognitive-Behavioral Therapy in Parkinson's Disease Comorbidities: A Literature Review». Clin Psychol Psychother (Review). PMID 32196842. doi:10.1002/cpp.2448}
- Spaulding, Sandi J., Brittany Barber, Morgan Colby, Bronwyn Cormack, Tanya Mick, et Mary E. Jenkins (2013). «Cueing and Gait Improvement among People with Parkinson's Disease: A Meta-Analysis». Archives of Physical Medicine and Rehabilitation. 94: 562–70. PMID 23127307. doi:10.1016/j.apmr.2012.10.026
- Bryant, M. S., D. H. Rintala, E. C. Lai, et E. J. Protas (2009). «An Evaluation of Self-Administration of Auditory Cueing to Improve Gait in People with Parkinson's Disease». Clinical Rehabilitation. 23: 1078–85. PMC 2877128. PMID 19565381. doi:10.1080/17483100903038576
- Morris ME, Iansek R, Matyas TA, Summers JJ (1996). «Stride length regulation in Parkinson's disease.Normalization strategies and underlying mechanisms». Brain. 119: 551–68. PMID 8800948. doi:10.1093/brain/119.2.551
- «Clinical Practice Guidelines Based on Evidence for Cognitive‐Behavioral Therapy in Parkinson's Disease Comorbidities: A Literature Review». Clinical Psychology & Psychotherapy. PMID 32196842. doi:10.1002/cpp.2448
- et al. (2002). «Long-term effect of body weight-supported treadmill training in Parkinson's disease: a randomized controlled trial». Arch Phys Med Rehabil. 83: 1370–73. PMID 12370870. doi:10.1053/apmr.2002.34603
- Amano S, Nocera JR, Vallabhajosula S, Juncos JL, Gregor RJ, Waddell DE, Wolf SL, Hass CJ (2013). «The effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's Disease». Parkinsonism Relat Disord. 19: 955–60. PMC 3825828. PMID 23835431. doi:10.1016/j.parkreldis.2013.06.007
- Hackney ME, Earhart GM (2008). «Tai Chi improves balance and mobility in people with Parkinson disease». Gait & Posture. 28: 456–60. PMC 2552999. PMID 18378456. doi:10.1016/j.gaitpost.2008.02.005
- Cannito MP, Suiter DM, Beverly D, Chorna L, Wolf T, Pfeiffer RM (2012). «Sentence Intelligibility Before and After Voice Treatment in Speakers With Idiopathic Parkinson's Disease». Journal of Voice. 26: 214–19. PMID 22209057. doi:10.1016/j.jvoice.2011.08.014
- «Speech and swallowing in parkinson's disease». Top Geriatric Rehabilitation. 28: 115–26. 2008. PMC 2784698. PMID 19946386. doi:10.1097/01.TGR.0000318899.87690.44
- Pacchetti C, Mancini F, Aglieri R, Fundaro C, Martignoni E, Nappi G (2000). «Active Music Therapy in Parkinson's Disease: An Integrative Method for Motor and Emotional Rehabilitation». Psychosomatic Medicine. 62: 386–93. CiteSeerX 10.1.1.555.3509. PMID 10845352. doi:10.1097/00006842-200005000-00012
- Beck. «National randomized controlled trial of virtual house calls for Parkinson disease». Neurology. 89: 1152–1161. ISSN 0028-3878. PMC 5595275. PMID 28814455. doi:10.1212/WNL.0000000000004357
- Dorsey. «National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers». Telemedicine and E-Health. 22: 590–598. ISSN 1530-5627. PMC 4939367. PMID 26886406. doi:10.1089/tmj.2015.0191
- Beck. «National randomized controlled trial of virtual house calls for Parkinson disease». Neurology. 89: 1152–1161. ISSN 1526-632X. PMC 5595275. PMID 28814455. doi:10.1212/WNL.0000000000004357
- Mammen. «Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study». Telemedicine and E-Health. 24: 255–267. ISSN 1530-5627. PMID 28787250. doi:10.1089/tmj.2017.0119
- Koch G (2010). «rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets». Restor. Neurol. Neurosci. 28: 561–68. PMID 20714078. doi:10.3233/RNN-2010-0556
- Platz T, Rothwell JC (2010). «Brain stimulation and brain repair – rTMS: from animal experiment to clinical trials – what do we know?». Restor. Neurol. Neurosci. 28: 387–98. PMID 20714064. doi:10.3233/RNN-2010-0570
- Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. «Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology». Neurology. 66: 976–82. PMID 16606908. doi:10.1212/01.wnl.0000206363.57955.1b
- Lee MS, Lam P, Ernst E. «Effectiveness of tai chi for Parkinson's disease: a critical review». Parkinsonism Relat. Disord. 14: 589–94. PMID 18374620. doi:10.1016/j.parkreldis.2008.02.003
- Lee MS, Ernst E. «Qigong for movement disorders: A systematic review». Mov. Disord. 24: 301–03. PMID 18973253. doi:10.1002/mds.22275
- Lee MS, Shin BC, Kong JC, Ernst E. «Effectiveness of acupuncture for Parkinson's disease: a systematic review». Mov. Disord. 23: 1505–15. PMID 18618661. doi:10.1002/mds.21993
- Katzenschlager R, Evans A, Manson A et al. (2004). «Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study». J. Neurol. Neurosurg. Psychiatry. 75: 1672–77. PMC 1738871. PMID 15548480. doi:10.1136/jnnp.2003.028761
- Ladha SS, Walker R, Shill HA. «Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance». Mov. Disord. 20: 630–31. PMID 15719433. doi:10.1002/mds.20380
- Raguthu L, Varanese S, Flancbaum L, Tayler E, Di Rocco A. «Fava beans and Parkinson's disease: useful 'natural supplement' or useless risk?». Eur. J. Neurol. 16. PMID 19678834. doi:10.1111/j.1468-1331.2009.02766.x
- Lanska DJ (2010). Chapter 33: the history of movement disorders. Col: Handbook of Clinical Neurology. 95. [S.l.: s.n.] pp. 501–46. ISBN 9780444520098. PMID 19892136. doi:10.1016/S0072-9752(08)02133-7
- Guridi J, Lozano AM. «A brief history of pallidotomy». Neurosurgery. 41: 1169–80; discussion 1180–83. PMID 9361073. doi:10.1097/00006123-199711000-00029
- Fahn S (2008). «The history of dopamine and levodopa in the treatment of Parkinson's disease». Mov. Disord. 23 Suppl 3: S497–508. PMID 18781671. doi:10.1002/mds.22028
- Fahn S (2008). «The history of dopamine and levodopa in the treatment of Parkinson's disease». Mov. Disord. 23 Suppl 3: S497–508. PMID 18781671. doi:10.1002/mds.22028
- Hornykiewicz O (2002). «L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent». Amino Acids. 23: 65–70. PMID 12373520. doi:10.1007/s00726-001-0111-9
- Coffey RJ. «Deep brain stimulation devices: a brief technical history and review». Artif Organs. 33: 208–20. PMID 18684199. doi:10.1111/j.1525-1594.2008.00620.x
- Obeso JA, Rodriguez-Oroz MC, Goetz CG et al. «Missing pieces in the Parkinson's disease puzzle». Nat Med. 16: 653–61. PMID 20495568. doi:10.1038/nm.2165
- Langston JW, Ballard P, Tetrud JW, Irwin I. «Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis» (PDF). Science. 219: 979–980. Bibcode:1983Sci...219..979L. PMID 6823561. doi:10.1126/science.6823561
- Cicchetti F, Drouin-Ouellet J, Gross RE. «Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?». Trends Pharmacol. Sci. 30: 475–83. PMID 19729209. doi:10.1016/j.tips.2009.06.005
- Transgenic rodent models of Parkinson's disease. Col: Acta Neurochirurgica Supplementum. 101. [S.l.: s.n.] 2008. pp. 89–92. ISBN 978-3-211-78204-0. PMC 2613245. PMID 18642640. doi:10.1007/978-3-211-78205-7_15
- Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW. «Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.». Lancet Neurology. 9: 1164–72. PMID 20970382. doi:10.1016/S1474-4422(10)70254-4. CN-00772567
- LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A. «AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial». Lancet Neurology. 10: 309–19. PMID 21419704. doi:10.1016/S1474-4422(11)70039-4. CN-00786419
- Feng, LR, Maguire-Zeiss KA (2010). «Gene Therapy in Parkinson's Disease: Rationale and Current Status». CNS Drugs. 24: 177–92. PMC 2886503. PMID 20155994. doi:10.2165/11533740-000000000-00000
- Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. (1 de maio de 2010). «Missing pieces in the Parkinson's disease puzzle». Nat Med. 16 (6): 653–61. PMID 20495568. doi:10.1038/nm.2165
- Redmond DE. «Cellular replacement therapy for Parkinson's disease – where we are today?». The Neuroscientist. 8: 457–88. PMID 12374430. doi:10.1177/107385802237703
parkinsons.org.uk
pdf.org
- «Archived copy» (PDF). Consultado em 12 de novembro de 2009. Cópia arquivada (PDF) em 24 de novembro de 2016
- «Archived copy» (PDF). Consultado em 12 de novembro de 2009. Cópia arquivada (PDF) em 18 de dezembro de 2009
- Donepezil (Aricept) Reduces Falls in People with Parkinson’s Arquivado em 2011-07-19 no Wayback Machine. Parkinson's Disease Foundation Science News. 11 November 2010.
psu.edu
citeseerx.ist.psu.edu
- Pacchetti C, Mancini F, Aglieri R, Fundaro C, Martignoni E, Nappi G (2000). «Active Music Therapy in Parkinson's Disease: An Integrative Method for Motor and Emotional Rehabilitation». Psychosomatic Medicine. 62: 386–93. CiteSeerX 10.1.1.555.3509. PMID 10845352. doi:10.1097/00006842-200005000-00012
sciencedaily.com
- «Stem Cell Research Aims to Tackle Parkinson's Disease». Consultado em 16 de abril de 2010
semanticscholar.org
pdfs.semanticscholar.org
- Langston JW, Ballard P, Tetrud JW, Irwin I. «Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis» (PDF). Science. 219: 979–980. Bibcode:1983Sci...219..979L. PMID 6823561. doi:10.1126/science.6823561
theguardian.com
web.archive.org
- «Archived copy» (PDF). Consultado em 12 de novembro de 2009. Cópia arquivada (PDF) em 24 de novembro de 2016
- «Archived copy» (PDF). Consultado em 12 de novembro de 2009. Cópia arquivada (PDF) em 18 de dezembro de 2009
- Donepezil (Aricept) Reduces Falls in People with Parkinson’s Arquivado em 2011-07-19 no Wayback Machine. Parkinson's Disease Foundation Science News. 11 November 2010.
- Parkinson's disease surgery Arquivado em 2010-03-30 no Wayback Machine neurology Channel. Retrieved on 2010-02-02
worldcat.org
- Morelli. «A2AReceptor Antagonism and Dyskinesia in Parkinson's Disease». Parkinson's Disease. 2012. 489853 páginas. ISSN 2090-8083. PMC 3382949. PMID 22754707. doi:10.1155/2012/489853
- Armentero. «Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease». Pharmacology & Therapeutics. 132: 280–299. ISSN 0163-7258. PMC 3205226. PMID 21810444. doi:10.1016/j.pharmthera.2011.07.004
- Warner. «The Role of Atomoxetine for Parkinson Disease-Related Executive Dysfunction: A Systematic Review». Journal of Clinical Psychopharmacology. 38: 627–631. ISSN 1533-712X. PMID 30346335. doi:10.1097/JCP.0000000000000963
- Dorsey. «Teleneurology and mobile technologies: the future of neurological care». Nature Reviews Neurology. 14: 285–297. ISSN 1759-4758. PMID 29623949. doi:10.1038/nrneurol.2018.31
- Beck. «National randomized controlled trial of virtual house calls for Parkinson disease». Neurology. 89: 1152–1161. ISSN 0028-3878. PMC 5595275. PMID 28814455. doi:10.1212/WNL.0000000000004357
- Dorsey. «National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers». Telemedicine and E-Health. 22: 590–598. ISSN 1530-5627. PMC 4939367. PMID 26886406. doi:10.1089/tmj.2015.0191
- Beck. «National randomized controlled trial of virtual house calls for Parkinson disease». Neurology. 89: 1152–1161. ISSN 1526-632X. PMC 5595275. PMID 28814455. doi:10.1212/WNL.0000000000004357
- Mammen. «Patient and Physician Perceptions of Virtual Visits for Parkinson's Disease: A Qualitative Study». Telemedicine and E-Health. 24: 255–267. ISSN 1530-5627. PMID 28787250. doi:10.1089/tmj.2017.0119
zenodo.org
- Samii A, Nutt JG, Ransom BR. «Parkinson's disease». Lancet. 363: 1783–93. PMID 15172778. doi:10.1016/S0140-6736(04)16305-8